Zobrazeno 1 - 10
of 232
pro vyhledávání: '"James M, Galvin"'
Autor:
Jimmy J. Caudell, Pedro A. Torres-Saavedra, David I. Rosenthal, Rita S. Axelrod, Phuc Felix Nguyen-Tan, Eric J. Sherman, Randal S. Weber, James M. Galvin, Adel K. El-Naggar, Andre A. Konski, Michelle I. Echevarria, Neal E. Dunlap, George Shenouda, Anurag K. Singh, Jonathan J. Beitler, Adam Garsa, James A. Bonner, Adam S. Garden, Ozer Algan, Jonathan Harris, Quynh-Thu Le
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: The combination of cisplatin and radiation or cetuximab and radiation improves overall survival of patients with locoregionally advanced head and neck carcinoma. NRG Oncology conducted a phase 3 trial to test the hypothesis that adding cetux
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08dcdb90cc6453e1c4fd3c86b36182df
https://doi.org/10.1016/j.ijrobp.2022.12.015
https://doi.org/10.1016/j.ijrobp.2022.12.015
Autor:
Minhee Won, Hui-Kuo Shu, James M. Galvin, John de Groot, Barbara Fisher, Jignesh M. Modi, Michael A. Vogelbaum, Minesh P. Mehta, Lynn S. Ashby, Shannon Fogh, Nimisha Deb, Peixin Zhang, C. Leland Rogers, Anthony M. Alleman, Emad Youssef, Clifford G. Robinson, Young Kwok, Arie Perry, William McMillan, Valerie Panet-Raymond
Publikováno v:
Int J Radiat Oncol Biol Phys
BACKGROUND: Phase 2 cooperative group meningioma trial assessing the safety and efficacy of risk-adaptive management strategies. This is the initial analysis of the high-risk cohort. METHODS AND MATERIALS: High-risk patients were those with a new or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9850100b4bceac66592e1443a99db627
https://doi.org/10.1016/j.ijrobp.2019.11.028
https://doi.org/10.1016/j.ijrobp.2019.11.028
Autor:
Thomas eFitzGerald, MD, Maryann eBishop-Jodoin, BS, Walter eBosch, DSc, Walter J. Curran, MD, David eFollowill, PhD, James M. Galvin, DSc, Richard eHanusik, AB, Steven R. King, MS, Michael V Knopp, MD, PhD, Fran eLaurie, BS, Elizabeth eO'Meara, BS, RT(R)(T), Jeff M. Michalski, MD, MBA, Joel H. Saltz, MD, PhD, Mitchell D. Schnall, MD, PhD, Lawrence eSchwartz, MD, Kenneth eUlin, PhD, Ying eXiao, PhD, Marcia M. Urie, PhD
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
The National Cancer Institute clinical cooperative groups have been instrumental over the past 50 years in developing clinical trials and evidence based process improvements for clinical oncology patient care. The cooperative groups are undergoing a
Externí odkaz:
https://doaj.org/article/32ceac8a07aa495b953730c0d44beb07
Autor:
David S. Followill, Marcia M Urie, James M. Galvin, Kenneth eUlin, Ying eXiao, Thomas eFitzgerald
Publikováno v:
Frontiers in Oncology, Vol 2 (2012)
The National Cancer Institute (NCI) clinical cooperative groups have been instrumental over the past 50 years in developing clinical trials and evidence based clinical trial processes for improvements in patient care. The cooperative groups are under
Externí odkaz:
https://doaj.org/article/384a493353a34985a74ff7911e382e66
Autor:
Eric E. Klein, Ying Xiao, Jason W. Sohn, James I. Monroe, Daniel A. Low, Karan Boparai, Haoyu Zhong, James M. Galvin, David S Followill, Jean M. Moran
Publikováno v:
Practical Radiation Oncology. 8:324-331
Purpose A survey was created by NRG to assess a medical physicists' percent full time equivalent (FTE) contribution to multi-institutional clinical trials. A 2012 American Society for Radiation Oncology report, "Safety Is No Accident," quantified med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6d346462ea8c55abb9be0266e23a0a
https://doi.org/10.1016/j.prro.2018.01.011
https://doi.org/10.1016/j.prro.2018.01.011
Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials
Autor:
Andrea Molineu, Jon J. Kruse, Robert Jeraj, James M. Galvin, Jean M. Moran, Arthur J. Olch, Mark Oldham, Jatinder R. Palta
Publikováno v:
Journal of Applied Clinical Medical Physics
The charge of AAPM Task Group 113 is to provide guidance for the physics aspects of clinical trials to minimize variability in planning and dose delivery for external beam trials involving photons and electrons. Several studies have demonstrated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e26ee225d26022effbf8f2a3c345f29
http://europepmc.org/articles/PMC6123105
http://europepmc.org/articles/PMC6123105
Autor:
R.U. Komaki, Jeffrey A. Bogart, V.S. Kavadi, Robert MacRae, James M. Galvin, Walter Bosch, Michael C. Dobelbower, Adam Raben, Puneeth Iyengar, Clifford G. Robinson, Rebecca Paulus, Samir Narayan, Mark E. Augspurger, Stephen G. Chun, Jeffrey D. Bradley, Robert Timmerman, Steven E. Schild, Raymond B. Wynn, Chen Hu, Hak Choy
Publikováno v:
Journal of Clinical Oncology. 35:56-62
Purpose Although intensity-modulated radiation therapy (IMRT) is increasingly used to treat locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional conformal external beam radiation therapy (3D-CRT) have not been compared pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f921a3451ef24d39366c1902e1d1f91c
https://doi.org/10.1200/jco.2016.69.1378
https://doi.org/10.1200/jco.2016.69.1378
Autor:
Jimmy J. Caudell, Jonathan J. Beitler, Anurag K. Singh, Phuc Felix Nguyen-Tan, James M. Galvin, Michael J. Birrer, Adel K. El-Naggar, Adam S. Garden, Terence S. Herman, Adam A. Garsa, Quynh-Thu Le, Randal S. Weber, Rita Axelrod, Eric J. Sherman, Andy Trotti, Pedro A. Torres-Saavedra, David I. Rosenthal, George Shenouda, Neal Dunlap, Andre Konski
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 106:1116-1117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::190c72e5bb03affc40c89bcaa8072dce
https://doi.org/10.1016/j.ijrobp.2019.11.393
https://doi.org/10.1016/j.ijrobp.2019.11.393
Autor:
Jose G. Bazan, Tarek Hijal, Julia White, James M. Galvin, Frank A. Vicini, Marc T. Fields, Michael Lock, Gary M. Freedman, Bethany Anderson, Susan McNulty, Janice A. Lyons, Douglas W. Arthur, Adam Currey, Ying Xiao, X. Allen Li, Jennifer Moughan, Kristine E. Kokeny, V.S. Kavadi, Melissa Mitchell, Sally B. Cheston
Publikováno v:
Pract Radiat Oncol
Purpose To investigate patterns of failure in institutional credentialing submissions to NRG/RTOG 1005 with the aim of improving the quality and consistency for future breast cancer protocols. Methods and Materials NRG/RTOG 1005 allowed the submissio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b8e7082696233ff026f2e15d83c6c0
https://europepmc.org/articles/PMC7255922/
https://europepmc.org/articles/PMC7255922/
Autor:
Christopher U. Jones, Weiqiang Zhao, Min Yao, Erich M. Sturgis, James J. Dignam, A. Dimitrios Colevas, Neal Dunlap, Jonathan Harris, Mohammed A. Razaq, James M. Galvin, Jolie Ringash, Shlomo A. Koyfman, Jack Phan, Andy Trotti, Quynh-Thu Le, Paul M. Harari, David J. Adelstein, Thomas J. Galloway, Avraham Eisbruch, John A. Ridge, Sharon A. Spencer, Jonathan J. Beitler, Barbara Burtness, Samantha A. Seaward, Richard C.K. Jordan, Dukagjin Blakaj, Maura L. Gillison
Publikováno v:
Lancet (London, England), vol 393, iss 10166
Summary Background Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma have high survival when treated with radiotherapy plus cisplatin. Whether replacement of cisplatin with cetuximab—an antibody against the epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84864adb48f1fe32178529499a50cb85
https://pubmed.ncbi.nlm.nih.gov/32145794
https://pubmed.ncbi.nlm.nih.gov/32145794